6446
569
TWD-2.00 (-0.35%)
2024.11.22收盤
藥華藥－現金流量表
合併現金流量表
第三季 (最新)
今年初累積至今
| (TWD千元) | 2024年前9個月 | 2023年前9個月 | 2022年前9個月 | 2021年前9個月 | 2020年前9個月 | 2019年前9個月 | 2018年前9個月 | 2017年前9個月 | 2016年前9個月 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | |
| 營業活動之現金流量-間接法 | ||||||||||||||||||
| 繼續營業單位稅前淨利（淨損） | 2,142,599 | 132.75% | (772,200) | 122.84% | (1,224,407) | 119.86% | (1,924,189) | 100.67% | (1,114,727) | 157.01% | (754,998) | 118.98% | (681,904) | 109.08% | (623,967) | 105.29% | (607,084) | 121.39% |
| 本期稅前淨利（淨損） | 2,142,599 | 132.75% | (772,200) | 122.84% | (1,224,407) | 119.86% | (1,924,189) | 100.67% | (1,114,727) | 157.01% | (754,998) | 118.98% | (681,904) | 109.08% | (623,967) | 105.29% | (607,084) | 121.39% |
| 調整項目 | ||||||||||||||||||
| 收益費損項目 | ||||||||||||||||||
| 折舊費用 | 234,835 | 14.55% | 138,575 | -22.04% | 159,053 | -15.57% | 162,845 | -8.52% | 124,514 | -17.54% | 97,010 | -15.29% | 39,778 | -6.36% | 44,413 | -7.49% | 44,198 | -8.84% |
| 攤銷費用 | 38,135 | 2.36% | 27,803 | -4.42% | 17,733 | -1.74% | 3,324 | -0.17% | 3,108 | -0.44% | 2,903 | -0.46% | 3,270 | -0.52% | 3,222 | -0.54% | 4,108 | -0.82% |
| 利息費用 | 16,896 | 1.05% | 40,647 | -6.47% | 7,957 | -0.78% | 7,558 | -0.4% | 5,885 | -0.83% | 5,559 | -0.88% | 1,203 | -0.19% | 1,313 | -0.22% | 1,423 | -0.28% |
| 利息收入 | (702,186) | -43.51% | (371,652) | 59.12% | (9,902) | 0.97% | (7,931) | 0.41% | (4,317) | 0.61% | (6,716) | 1.06% | (13,536) | 2.17% | ||||
| 股利收入 | (6,603) | -0.41% | ||||||||||||||||
| 股份基礎給付酬勞成本 | 130,707 | 8.1% | 638,008 | -101.49% | 202,201 | -19.79% | 25,945 | -1.36% | 47,023 | -6.62% | 105,572 | -16.64% | 40,740 | -6.52% | ||||
| 處分及報廢不動產、廠房及設備損失（利益） | 343 | 0.02% | 0 | 0% | 69 | 0% | (17) | 0% | (143) | 0.02% | (140) | 0.02% | ||||||
| 收益費損項目合計 | (287,873) | -17.84% | 473,381 | -75.3% | 377,141 | -36.92% | 191,810 | -10.04% | 167,640 | -23.61% | 204,185 | -32.18% | 71,315 | -11.41% | 83,039 | -14.01% | 128,131 | -25.62% |
| 與營業活動相關之資產/負債變動數 | ||||||||||||||||||
| 與營業活動相關之資產之淨變動 | ||||||||||||||||||
| 應收票據（增加）減少 | 0 | 0% | 224 | -0.04% | (224) | 0.02% | 0 | 0% | 0 | 0% | (90) | 0.01% | 0 | 0% | 0 | 0% | (24) | 0% |
| 應收帳款（增加）減少 | (843,597) | -52.27% | (602,117) | 95.78% | (208,858) | 20.45% | 58,929 | -3.08% | 192,838 | -27.16% | 22,494 | -3.54% | 427 | -0.07% | 909 | -0.15% | (141) | 0.03% |
| 其他應收款（增加）減少 | 149,056 | 9.24% | (15,532) | 2.47% | 4,629 | -0.45% | 1,872 | -0.1% | (26) | 0.01% | ||||||||
| 存貨（增加）減少 | 31,901 | 1.98% | (430,447) | 68.47% | (144,080) | 14.1% | (234,712) | 12.28% | (210,624) | 29.67% | (151,363) | 23.85% | (9,123) | 1.46% | (26,736) | 4.51% | (3,994) | 0.8% |
| 預付款項（增加）減少 | (70,717) | -4.38% | (172,339) | 27.41% | (69,973) | 6.85% | (31,642) | 1.66% | 2,996 | -0.42% | (24,734) | 3.9% | (19,629) | 3.14% | (9,085) | 1.53% | 824 | -0.16% |
| 其他流動資產（增加）減少 | (13,359) | -0.83% | 38,033 | -6.05% | (5,420) | 0.53% | (6,018) | 0.31% | 3,114 | -0.44% | (4,128) | 0.65% | 534 | -0.09% | ||||
| 與營業活動相關之資產之淨變動合計 | (746,716) | -46.27% | (1,182,178) | 188.06% | (423,926) | 41.5% | (211,571) | 11.07% | (11,676) | 1.64% | (157,821) | 24.87% | (27,791) | 4.45% | (35,529) | 6% | (3,921) | 0.78% |
| 與營業活動相關之負債之淨變動 | ||||||||||||||||||
| 應付票據增加（減少） | 37 | 0% | (5) | 0% | (75) | 0.01% | (35) | 0% | 28 | 0% | (8) | 0% | (325) | 0.05% | 77 | -0.01% | 202 | -0.04% |
| 應付帳款增加（減少） | 2,478 | 0.15% | (108,745) | 17.3% | 16,935 | -1.66% | (46,457) | 2.43% | 30,556 | -4.3% | 6,109 | -0.96% | (215) | 0.03% | (1,727) | 0.29% | (4,233) | 0.85% |
| 其他應付款增加（減少） | (292,452) | -18.12% | 502,441 | -79.93% | 136,191 | -13.33% | (34,910) | 1.83% | 81,280 | -11.45% | 58,890 | -9.28% | 3,368 | -0.54% | (30,241) | 5.1% | (17,231) | 3.45% |
| 負債準備增加（減少） | 134,213 | 8.32% | ||||||||||||||||
| 其他流動負債增加（減少） | 78,075 | 4.84% | 12,353 | -1.97% | (7,502) | 0.73% | 47,591 | -2.49% | 111,660 | -15.73% | 2,424 | -0.38% | (2,084) | 0.33% | ||||
| 淨確定福利負債增加(減少) | 1,173 | 0.07% | (3,039) | 0.48% | (186) | 0.02% | 357 | -0.02% | (174) | 0.02% | (120) | 0.02% | (113) | 0.02% | (204) | 0.03% | (172) | 0.03% |
| 其他營業負債增加（減少） | 52,710 | 3.27% | 160,301 | -25.5% | 94,671 | -9.27% | 49,325 | -2.58% | 19,819 | -2.79% | ||||||||
| 與營業活動相關之負債之淨變動合計 | (23,766) | -1.47% | 563,306 | -89.61% | 239,738 | -23.47% | 23,931 | -1.25% | 243,482 | -34.29% | 67,295 | -10.6% | 631 | -0.1% | (31,489) | 5.31% | (19,879) | 3.97% |
| 與營業活動相關之資產及負債之淨變動合計 | (770,482) | -47.74% | (618,872) | 98.45% | (184,188) | 18.03% | (187,640) | 9.82% | 231,806 | -32.65% | (90,526) | 14.27% | (27,160) | 4.34% | (67,018) | 11.31% | (23,800) | 4.76% |
| 調整項目合計 | (1,058,355) | -65.57% | (145,491) | 23.14% | 192,953 | -18.89% | 4,170 | -0.22% | 399,446 | -56.26% | 113,659 | -17.91% | 44,155 | -7.06% | 16,021 | -2.7% | 104,331 | -20.86% |
| 營運產生之現金流入（流出） | 1,084,244 | 67.18% | (917,691) | 145.98% | (1,031,454) | 100.97% | (1,920,019) | 100.46% | (715,281) | 100.75% | (641,339) | 101.07% | (637,749) | 102.01% | (607,946) | 102.59% | (502,753) | 100.53% |
| 收取之利息 | 697,656 | 43.23% | 332,355 | -52.87% | 9,983 | -0.98% | 8,789 | -0.46% | 6,066 | -0.85% | 6,917 | -1.09% | 12,639 | -2.02% | 14,691 | -2.48% | 2,707 | -0.54% |
| 退還（支付）之所得稅 | (167,925) | -10.4% | (43,298) | 6.89% | (81) | 0.01% | (58) | 0% | (757) | 0.11% | (152) | 0.02% | (45) | 0.01% | 659 | -0.11% | (65) | 0.01% |
| 營業活動之淨現金流入（流出） | 1,613,975 | 100% | (628,634) | 100% | (1,021,552) | 100% | (1,911,288) | 100% | (709,972) | 100% | (634,574) | 100% | (625,155) | 100% | (592,596) | 100% | (500,111) | 100% |
| 投資活動之現金流量 | ||||||||||||||||||
| 透過其他綜合損益按公允價值衡量之金融資產減資退回股款 | 25,000 | -5.41% | ||||||||||||||||
| 取得按攤銷後成本衡量之金融資產 | (1,117) | 0.24% | 0 | 0% | (145) | 0.12% | 0 | 0% | (69,311) | 32.58% | 0 | 0% | (35,555) | 25.53% | ||||
| 按攤銷後成本衡量之金融資產到期還本 | 0 | 0% | 970,425 | 564.31% | 0 | 0% | 62,751 | -95.1% | 0 | 0% | 16,926 | -14.23% | 10,670 | -7.66% | ||||
| 取得透過損益按公允價值衡量之金融資產 | 0 | 0% | (96,000) | -55.82% | 0 | 0% | (25,000) | 37.89% | ||||||||||
| 取得不動產、廠房及設備 | (373,938) | 80.9% | (499,792) | -290.63% | (187,488) | 154.96% | (50,183) | 76.06% | (38,955) | 18.31% | (51,156) | 43.02% | (14,223) | 10.21% | (8,742) | 32.37% | (2,437) | 18.81% |
| 取得無形資產 | (7,729) | 1.67% | (28,509) | -16.58% | (2,509) | 2.07% | (24,700) | 37.44% | (86,135) | 40.49% | (1,035) | 0.87% | (736) | 0.53% | (1,650) | 6.11% | (1,918) | 14.81% |
| 其他非流動資產增加 | (33,258) | 7.19% | (35,791) | -20.81% | 112,122 | -92.67% | (22,584) | 34.23% | (10,159) | 4.78% | (18,281) | 15.37% | (12,490) | 8.97% | (14,164) | 52.45% | (813) | 6.28% |
| 預付設備款增加 | (77,801) | 16.83% | (138,367) | -80.46% | (42,968) | 35.51% | (6,265) | 9.5% | (6,671) | 3.14% | (40,519) | 34.07% | (87,090) | 62.54% | (2,449) | 9.07% | (7,787) | 60.11% |
| 收取之股利 | 6,603 | -1.43% | ||||||||||||||||
| 投資活動之淨現金流入（流出） | (462,240) | 100% | 171,966 | 100% | (120,988) | 100% | (65,981) | 100% | (212,732) | 100% | (118,922) | 100% | (139,244) | 100% | (27,005) | 100% | (12,955) | 100% |
| 籌資活動之現金流量 | ||||||||||||||||||
| 短期借款減少 | (21,000) | 10.26% | (973,875) | -9.28% | 0 | 0% | (20,000) | 10.79% | 0 | 0% | (10,000) | 73.66% | ||||||
| 償還長期借款 | (9,273) | 4.53% | (8,997) | -0.09% | (9,017) | -0.5% | (4,483) | 2.42% | (2,900) | -0.08% | (4,350) | 9.87% | (4,350) | 32.04% | (4,350) | 103.79% | (4,350) | -0.1% |
| 租賃本金償還 | (179,533) | 87.75% | (92,422) | -0.88% | (87,678) | -4.84% | (81,517) | 43.96% | (59,881) | -1.59% | (40,410) | 91.71% | ||||||
| 現金增資 | 0 | 0% | 13,876,760 | 132.24% | 1,833,500 | 101.31% | 0 | 0% | 3,812,800 | 101.51% | 0 | 0% | 0 | 0% | 0 | 0% | 4,143,387 | 99.42% |
| 員工執行認股權 | 6,931 | -3.39% | 390,017 | 3.72% | 73,644 | 4.07% | 9,906 | -5.34% | 7,127 | 0.19% | 3,922 | -8.9% | 4,086 | -30.1% | 4,426 | -105.61% | 30,655 | 0.74% |
| 庫藏股票買回成本 | 0 | 0% | (2,663,904) | -25.39% | 0 | 0% | (87,502) | 47.19% | ||||||||||
| 支付之利息 | (1,717) | 0.84% | (33,672) | -0.32% | (1,800) | -0.1% | (1,825) | 0.98% | (999) | -0.03% | (1,221) | 2.77% | (1,203) | 8.86% | (1,313) | 31.33% | (1,423) | -0.03% |
| 籌資活動之淨現金流入（流出） | (204,592) | 100% | 10,493,907 | 100% | 1,809,735 | 100% | (185,421) | 100% | 3,756,147 | 100% | (44,064) | 100% | (13,576) | 100% | (4,191) | 100% | 4,167,555 | 100% |
| 匯率變動對現金及約當現金之影響 | 218,644 | 191,730 | 19,303 | (14,451) | 891 | 3,745 | 1,293 | (1,300) | (831) | |||||||||
| 本期現金及約當現金增加（減少）數 | 1,165,787 | 10,228,969 | 686,498 | (2,177,141) | 2,834,334 | (793,815) | (776,682) | (625,092) | 3,653,658 | |||||||||
| 期初現金及約當現金餘額 | 19,666,029 | 10,303,658 | 3,453,645 | 3,200,378 | 1,395,675 | 2,166,881 | 3,185,931 | 4,044,342 | 563,909 | |||||||||
| 期末現金及約當現金餘額 | 20,831,816 | 20,532,627 | 4,140,143 | 1,023,237 | 4,230,009 | 1,373,066 | 2,409,249 | 3,419,250 | 4,217,567 | |||||||||
| 資產負債表帳列之現金及約當現金 | 20,831,816 | 20,532,627 | 4,140,143 | 1,023,237 | 4,230,009 | 1,373,066 | 2,409,249 | 3,419,250 | 4,217,567 | |||||||||
需注意：由於會計政策的變動，部分現行會計科目在過往資料中，可能名稱不同，或是合併於其他科目中。此外，過往會計科目也可能消失。 然而我們盡力確保表中各項目之數值與公司公布之財報相符。以上資訊僅供參考，實際數據仍以公司公布之財報為準。
營業活動之現金流
藥華藥(6446) 2024年第3季「營業活動之現金流」單季為NT$10.48億元、較上一季成長21.34%；而今年初至今累積為NT$16.14億元、較去年同期成長356.74%。
單季
藥華藥(6446) 最新公布的2024年第3季財報中，本季新增之「營業活動之現金流」為NT$10.48億元，較上一季成長21.34%，為過去10年同期中的第1高。
同時藥華藥過去3年與5年的「第3季營業活動之現金流年化成長率」分別為58.75%與。
其中稅前淨利為NT$8.81億元，收益費損相關之調整項目為NT$-1.27億元，所得稅/利息等之影響數為NT$1.57億元
今年初累積至今
今年前9個月營業活動之現金流累積為NT$16.14億元，較去年同期成長356.74%，為過去10年同期中的第1高。
同時藥華藥過去3年與5年的「前9個月營業活動之現金流年化成長率」分別為41.69%與。
其中稅前淨利為NT$21.43億元，收益費損相關之調整項目為NT$-2.88億元，所得稅/利息等之影響數為NT$5.3億元
營業活動之現金流-今年初累積至今
| (TWD千元) | 2024年前9個月 | 2023年前9個月 | 2022年前9個月 | 2021年前9個月 | 2020年前9個月 | 2019年前9個月 | 2018年前9個月 | 2017年前9個月 | 2016年前9個月 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | |
| 繼續營業單位稅前淨利（淨損） | 2,142,599 | 132.75% | (772,200) | 122.84% | (1,224,407) | 119.86% | (1,924,189) | 100.67% | (1,114,727) | 157.01% | (754,998) | 118.98% | (681,904) | 109.08% | (623,967) | 105.29% | (607,084) | 121.39% |
| 收益費損項目合計 | (287,873) | -17.84% | 473,381 | -75.3% | 377,141 | -36.92% | 191,810 | -10.04% | 167,640 | -23.61% | 204,185 | -32.18% | 71,315 | -11.41% | 83,039 | -14.01% | 128,131 | -25.62% |
| 折舊費用 | 234,835 | 14.55% | 138,575 | -22.04% | 159,053 | -15.57% | 162,845 | -8.52% | 124,514 | -17.54% | 97,010 | -15.29% | 39,778 | -6.36% | 44,413 | -7.49% | 44,198 | -8.84% |
| 攤銷費用 | 38,135 | 2.36% | 27,803 | -4.42% | 17,733 | -1.74% | 3,324 | -0.17% | 3,108 | -0.44% | 2,903 | -0.46% | 3,270 | -0.52% | 3,222 | -0.54% | 4,108 | -0.82% |
| 與營業活動相關之資產及負債之淨變動合計 | (770,482) | -47.74% | (618,872) | 98.45% | (184,188) | 18.03% | (187,640) | 9.82% | 231,806 | -32.65% | (90,526) | 14.27% | (27,160) | 4.34% | (67,018) | 11.31% | (23,800) | 4.76% |
| 營業活動之淨現金流入（流出） | 1,613,975 | 100% | (628,634) | 100% | (1,021,552) | 100% | (1,911,288) | 100% | (709,972) | 100% | (634,574) | 100% | (625,155) | 100% | (592,596) | 100% | (500,111) | 100% |
投資活動之淨現金流
藥華藥(6446) 2024年第3季「投資活動之淨現金流」單季為NT$-2.08億元、較上一季衰退-118.35%；而今年初至今累積為NT$-4.62億元、較去年同期衰退-368.8%。
單季
藥華藥(6446) 最新公布的2024年第3季財報中，本季新增之「投資活動之淨現金流」為NT$-2.08億元，較上一季衰退-118.35%，為過去10年同期中的第9高。
今年初累積至今
今年前9個月投資活動之淨現金流累積為NT$-4.62億元，較去年同期衰退-368.8%，為過去10年同期中的第9高。
投資活動之淨現金流-今年初累積至今
| (TWD千元) | 2024年前9個月 | 2023年前9個月 | 2022年前9個月 | 2021年前9個月 | 2020年前9個月 | 2019年前9個月 | 2018年前9個月 | 2017年前9個月 | 2016年前9個月 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | |
| 投資活動之淨現金流入（流出） | (462,240) | 100% | 171,966 | 100% | (120,988) | 100% | (65,981) | 100% | (212,732) | 100% | (118,922) | 100% | (139,244) | 100% | (27,005) | 100% | (12,955) | 100% |
| 取得不動產、廠房及設備 | (373,938) | 80.9% | (499,792) | -290.63% | (187,488) | 154.96% | (50,183) | 76.06% | (38,955) | 18.31% | (51,156) | 43.02% | (14,223) | 10.21% | (8,742) | 32.37% | (2,437) | 18.81% |
| 處分不動產、廠房及設備 | 0 | 0% | 0 | 0% | 230 | -0.11% | 143 | -0.12% | 180 | -0.13% | ||||||||
| 取得無形資產 | (7,729) | 1.67% | (28,509) | -16.58% | (2,509) | 2.07% | (24,700) | 37.44% | (86,135) | 40.49% | (1,035) | 0.87% | (736) | 0.53% | (1,650) | 6.11% | (1,918) | 14.81% |
| 處分無形資產 | ||||||||||||||||||
| 取得透過損益按公允價值衡量之金融資產 | 0 | 0% | (96,000) | -55.82% | 0 | 0% | (25,000) | 37.89% | ||||||||||
| 處分透過損益按公允價值衡量之金融資產 | ||||||||||||||||||
| 取得透過其他綜合損益按公允價值衡量之金融資產 | 0 | 0% | 0 | 0% | 0 | 0% | (25,000) | 21.02% | ||||||||||
| 處分透過其他綜合損益按公允價值衡量之金融資產 | ||||||||||||||||||
| 取得按攤銷後成本衡量之金融資產 | (1,117) | 0.24% | 0 | 0% | (145) | 0.12% | 0 | 0% | (69,311) | 32.58% | 0 | 0% | (35,555) | 25.53% | ||||
| 處分按攤銷後成本衡量之金融資產 | ||||||||||||||||||
| 按攤銷後成本衡量之金融資產到期還本 | 0 | 0% | 970,425 | 564.31% | 0 | 0% | 62,751 | -95.1% | 0 | 0% | 16,926 | -14.23% | 10,670 | -7.66% | ||||
籌資活動之淨現金流
藥華藥(6446) 2024年第3季「籌資活動之淨現金流」單季為NT$-6,436萬元、較上一季成長9.09%；而今年初至今累積為NT$-2.05億元、較去年同期衰退-101.95%。
單季
藥華藥(6446) 最新公布的2024年第3季財報中，本季新增之「籌資活動之淨現金流」為NT$-6,436萬元，較上一季成長9.09%，為過去10年同期中的第8高。
今年初累積至今
今年前9個月籌資活動之淨現金流累積為NT$-2.05億元，較去年同期衰退-101.95%，為過去10年同期中的第9高。
籌資活動之淨現金流-今年初累積至今
| (TWD千元) | 2024年前9個月 | 2023年前9個月 | 2022年前9個月 | 2021年前9個月 | 2020年前9個月 | 2019年前9個月 | 2018年前9個月 | 2017年前9個月 | 2016年前9個月 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | 金額 | % | |
| 籌資活動之淨現金流入（流出） | (204,592) | 100% | 10,493,907 | 100% | 1,809,735 | 100% | (185,421) | 100% | 3,756,147 | 100% | (44,064) | 100% | (13,576) | 100% | (4,191) | 100% | 4,167,555 | 100% |
| 短期借款增加 | 0 | 0% | 1,086 | 0.06% | 0 | 0% | 0 | 0% | 0 | 0% | 0 | 0% | ||||||
| 短期借款減少 | (21,000) | 10.26% | (973,875) | -9.28% | 0 | 0% | (20,000) | 10.79% | 0 | 0% | (10,000) | 73.66% | ||||||
| 發行公司債 | ||||||||||||||||||
| 償還公司債 | ||||||||||||||||||
| 舉借長期借款 | ||||||||||||||||||
| 償還長期借款 | (9,273) | 4.53% | (8,997) | -0.09% | (9,017) | -0.5% | (4,483) | 2.42% | (2,900) | -0.08% | (4,350) | 9.87% | (4,350) | 32.04% | (4,350) | 103.79% | (4,350) | -0.1% |
| 發放現金股利 | ||||||||||||||||||
| 庫藏股票買回成本 | 0 | 0% | (2,663,904) | -25.39% | 0 | 0% | (87,502) | 47.19% | ||||||||||
ifa.ai自當盡力提供正確訊息，但如有疏忽或錯誤遺漏，本公司或關係企業與其任何董事或任何受僱人，恕不負任何法律責任。
